Cargando…

Particle toxicology and health - where are we?

BACKGROUND: Particles and fibres affect human health as a function of their properties such as chemical composition, size and shape but also depending on complex interactions in an organism that occur at various levels between particle uptake and target organ responses. While particulate pollution i...

Descripción completa

Detalles Bibliográficos
Autores principales: Riediker, Michael, Zink, Daniele, Kreyling, Wolfgang, Oberdörster, Günter, Elder, Alison, Graham, Uschi, Lynch, Iseult, Duschl, Albert, Ichihara, Gaku, Ichihara, Sahoko, Kobayashi, Takahiro, Hisanaga, Naomi, Umezawa, Masakazu, Cheng, Tsun-Jen, Handy, Richard, Gulumian, Mary, Tinkle, Sally, Cassee, Flemming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480662/
https://www.ncbi.nlm.nih.gov/pubmed/31014371
http://dx.doi.org/10.1186/s12989-019-0302-8
_version_ 1783413617028235264
author Riediker, Michael
Zink, Daniele
Kreyling, Wolfgang
Oberdörster, Günter
Elder, Alison
Graham, Uschi
Lynch, Iseult
Duschl, Albert
Ichihara, Gaku
Ichihara, Sahoko
Kobayashi, Takahiro
Hisanaga, Naomi
Umezawa, Masakazu
Cheng, Tsun-Jen
Handy, Richard
Gulumian, Mary
Tinkle, Sally
Cassee, Flemming
author_facet Riediker, Michael
Zink, Daniele
Kreyling, Wolfgang
Oberdörster, Günter
Elder, Alison
Graham, Uschi
Lynch, Iseult
Duschl, Albert
Ichihara, Gaku
Ichihara, Sahoko
Kobayashi, Takahiro
Hisanaga, Naomi
Umezawa, Masakazu
Cheng, Tsun-Jen
Handy, Richard
Gulumian, Mary
Tinkle, Sally
Cassee, Flemming
author_sort Riediker, Michael
collection PubMed
description BACKGROUND: Particles and fibres affect human health as a function of their properties such as chemical composition, size and shape but also depending on complex interactions in an organism that occur at various levels between particle uptake and target organ responses. While particulate pollution is one of the leading contributors to the global burden of disease, particles are also increasingly used for medical purposes. Over the past decades we have gained considerable experience in how particle properties and particle-bio interactions are linked to human health. This insight is useful for improved risk management in the case of unwanted health effects but also for developing novel medical therapies. The concepts that help us better understand particles’ and fibres’ risks include the fate of particles in the body; exposure, dosimetry and dose-metrics and the 5 Bs: bioavailability, biopersistence, bioprocessing, biomodification and bioclearance of (nano)particles. This includes the role of the biomolecule corona, immunity and systemic responses, non-specific effects in the lungs and other body parts, particle effects and the developing body, and the link from the natural environment to human health. The importance of these different concepts for the human health risk depends not only on the properties of the particles and fibres, but is also strongly influenced by production, use and disposal scenarios. CONCLUSIONS: Lessons learned from the past can prove helpful for the future of the field, notably for understanding novel particles and fibres and for defining appropriate risk management and governance approaches.
format Online
Article
Text
id pubmed-6480662
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64806622019-05-01 Particle toxicology and health - where are we? Riediker, Michael Zink, Daniele Kreyling, Wolfgang Oberdörster, Günter Elder, Alison Graham, Uschi Lynch, Iseult Duschl, Albert Ichihara, Gaku Ichihara, Sahoko Kobayashi, Takahiro Hisanaga, Naomi Umezawa, Masakazu Cheng, Tsun-Jen Handy, Richard Gulumian, Mary Tinkle, Sally Cassee, Flemming Part Fibre Toxicol Review BACKGROUND: Particles and fibres affect human health as a function of their properties such as chemical composition, size and shape but also depending on complex interactions in an organism that occur at various levels between particle uptake and target organ responses. While particulate pollution is one of the leading contributors to the global burden of disease, particles are also increasingly used for medical purposes. Over the past decades we have gained considerable experience in how particle properties and particle-bio interactions are linked to human health. This insight is useful for improved risk management in the case of unwanted health effects but also for developing novel medical therapies. The concepts that help us better understand particles’ and fibres’ risks include the fate of particles in the body; exposure, dosimetry and dose-metrics and the 5 Bs: bioavailability, biopersistence, bioprocessing, biomodification and bioclearance of (nano)particles. This includes the role of the biomolecule corona, immunity and systemic responses, non-specific effects in the lungs and other body parts, particle effects and the developing body, and the link from the natural environment to human health. The importance of these different concepts for the human health risk depends not only on the properties of the particles and fibres, but is also strongly influenced by production, use and disposal scenarios. CONCLUSIONS: Lessons learned from the past can prove helpful for the future of the field, notably for understanding novel particles and fibres and for defining appropriate risk management and governance approaches. BioMed Central 2019-04-23 /pmc/articles/PMC6480662/ /pubmed/31014371 http://dx.doi.org/10.1186/s12989-019-0302-8 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Riediker, Michael
Zink, Daniele
Kreyling, Wolfgang
Oberdörster, Günter
Elder, Alison
Graham, Uschi
Lynch, Iseult
Duschl, Albert
Ichihara, Gaku
Ichihara, Sahoko
Kobayashi, Takahiro
Hisanaga, Naomi
Umezawa, Masakazu
Cheng, Tsun-Jen
Handy, Richard
Gulumian, Mary
Tinkle, Sally
Cassee, Flemming
Particle toxicology and health - where are we?
title Particle toxicology and health - where are we?
title_full Particle toxicology and health - where are we?
title_fullStr Particle toxicology and health - where are we?
title_full_unstemmed Particle toxicology and health - where are we?
title_short Particle toxicology and health - where are we?
title_sort particle toxicology and health - where are we?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480662/
https://www.ncbi.nlm.nih.gov/pubmed/31014371
http://dx.doi.org/10.1186/s12989-019-0302-8
work_keys_str_mv AT riedikermichael particletoxicologyandhealthwherearewe
AT zinkdaniele particletoxicologyandhealthwherearewe
AT kreylingwolfgang particletoxicologyandhealthwherearewe
AT oberdorstergunter particletoxicologyandhealthwherearewe
AT elderalison particletoxicologyandhealthwherearewe
AT grahamuschi particletoxicologyandhealthwherearewe
AT lynchiseult particletoxicologyandhealthwherearewe
AT duschlalbert particletoxicologyandhealthwherearewe
AT ichiharagaku particletoxicologyandhealthwherearewe
AT ichiharasahoko particletoxicologyandhealthwherearewe
AT kobayashitakahiro particletoxicologyandhealthwherearewe
AT hisanaganaomi particletoxicologyandhealthwherearewe
AT umezawamasakazu particletoxicologyandhealthwherearewe
AT chengtsunjen particletoxicologyandhealthwherearewe
AT handyrichard particletoxicologyandhealthwherearewe
AT gulumianmary particletoxicologyandhealthwherearewe
AT tinklesally particletoxicologyandhealthwherearewe
AT casseeflemming particletoxicologyandhealthwherearewe